XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.1

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Calculations of Earnings Per Share

The calculations of earnings per share are as follows:

			Three Months Ended March 31,
($ and shares in millions except per share amounts)			2023						2022
Net Income Attributable to Merck & Co., Inc.			$	2,821					$	4,310
Average common shares outstanding			2,538						2,528
Common shares issuable (1)			13						9
Average common shares outstanding assuming dilution			2,551						2,537
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders			$	1.11					$	1.70
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders			$	1.11					$	1.70

(1)    Issuable primarily under share-based compensation plans.

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration